Read the Latest News

And the Committee heard from the American Association of Oral and Maxillofacial Surgeons

At the end of the NAM meeting, Dr. Gregory Ness, representing the American Association of Oral and Maxillofacial Surgeons (AAMOS) gave the following comments: “AAMOS welcomes the interest and support of the Academies, the NIH, NIDCR, FDA and The

What Allen Told the Committee

Allen Cowley addressed the second open-to-the-public meeting of the National Institute of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD) held on March 28, 2019 in Washington, DC. No stranger to the world of TMD, Dr. Cowley is the hus

Some Thoughts on Depression

It is hardly surprising that the chronic pain and limitations in function that many long-time TMJ patients experience can be accompanied by a state of depression, a sense of exhaustion and hopelessness.

Upcoming NAM Public Webinars on TMD

The National Academy of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment is hosting two public web conferences on Wednesday, June 19 and Wednesday, July 31.   Webinar 1: Pati

The NAM Committee Heard from Patients, Too

At the March 28, 2019 public meeting NAM committee members had a chance to hear from TMD patients who had submitted testimony for the record.

Low-Level Laser Therapy

  • Jul 11, 2018

Low-Level therapy (also known as cold laser therapy) is another treatment that has been promoted to patients with chronic pain conditions who are desperately seeking relief. This treatment is recommended for a diverse conditions such as back and neck pain, musculoskeletal pain, arthritis, fibromyalgia, tendonitis, bursitis, neuropathy, migraine headaches, sprains and strains, carpal tunnel syndrome and temporomandibular disorders.

Latest Scientific News/Research on Low-Level Laser Therapy

  • Zokaee H, Akbari Zahmati AH, Mojrian N, Boostani A, Vaghari M. Efficacy of low-level laser therapy on orofacial pain: A literature review. Adv Hum Biol [serial online] 2018 [cited 2018 Jul 11];8:70-3. Available from: http://www.aihbonline.com/text.asp?2018/8/2/70/232017. Conclusion: As an overall result, it is concluded that LLLT can be served as a therapeutic method for myofascial pain, mucositis and temporomandibular joint disorders and this is due to its analgesic features.
  • Fernando M. Munguia, DDS, MS/John Jang, DMD, MS/Mahmoud Salem, DDS, MS/Glenn T. Clark, DDS, MS/Reyes Enciso, PhD, Efficacy of Low-Level Laser Therapy in the Treatment of Temporomandibular Myofascial Pain: A Systematic Review and Meta-Analysis. Journal of Oral & Facial Pain and Headache The findings from this systematic review showed that LLLT seems to be effective in reducing pain in patients with temporomandibular myofascial pain with moderate-quality evidence. However, due to the high heterogeneity, small number, and high risk of bias of the included studies, the results are not definitive, and further well-designed studies are needed.
  • Shukla D, Muthusekhar MR. Efficacy of low-level laser therapy in temporomandibular disorders: A systematic review. National Journal of Maxillofacial Surgery. 2016;7(1):62-66. doi:10.4103/0975-5950.196127.  Conclusion: Our results have shown that LLLT seems to be effective in reducing pain in TMD's. It may be a treatment option for patients with an interest in a noninvasive, complementary therapy.